The beneficial effects of anti-Il-17 in LPS exacerbated asthma in murine models [9,10,11,12] and in the alleviation of ALI inflammation [19], possibly by reducing the expression of cytokines and oxidative stress [13], were already evaluated. This evidence concerns the gene IL17A and asthma.